|
Real-time Estimate
Cboe BZX
01:16:46 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 124.91 USD | -1.17% |
|
+3.82% | +19.32% |
| 16/10 | William Blair Initiates Coverage on Palvella Therapeutics With Outperform Rating | MT |
| 15/10 | Palvella Therapeutics Insider Sold Shares Worth $3,579,476, According to a Recent SEC Filing | MT |
| Market Cap | 182.11Cr 162.62Cr 150.23Cr 136.14Cr 254.71Cr 17TCr 258.92Cr 1.81TCr 715.74Cr 9.06TCr 683.43Cr 668.9Cr 29TCr | P/E 2026 * |
-19.2x | P/E 2027 * | -14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 163.05Cr 145.6Cr 134.51Cr 121.89Cr 228.05Cr 15TCr 231.82Cr 1.62TCr 640.83Cr 8.11TCr 611.9Cr 598.89Cr 26TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 73.9x |
| Free-Float |
88.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PVLA | Delayed | |
CBOE
| PVLA | Real-time | |
|
Tradegate
| PI6 | Real-time | |
|
Deutsche Boerse AG
| PI6 | End-of-day quote | |
|
Boerse Muenchen
| PI6 | Real-time |
Last Transcript: Palvella Therapeutics, Inc.
| 1 day | -1.17% | ||
| 1 week | +3.82% | ||
| Current month | -9.45% | ||
| 1 month | -16.50% | ||
| 3 months | -12.79% | ||
| 6 months | -1.70% | ||
| Current year | +19.32% |
| 1 week | 120.75 |  | 131.03 |
| 1 month | 118.22 | | 149.11 |
| Current year | 72.22 | | 161.38 |
| 1 year | 68.96 | | 161.38 |
| 3 years | 11.17 | | 161.38 |
| 5 years | 11.17 | | 161.38 |
| 10 years | 11.17 | | 161.38 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Sell | Chairman | -7,174 | 0.0498% | ||
| 16/09/26 | Exercice | Chief Operating Officer | 12,906 | 0.0896% | ||
| 15/09/26 | Sell | Chairman | -1,777 | 0.0123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | +3.82% | +75.16% | - | 182.11Cr | |
| +2.41% | -6.33% | +43.43% | +71.02% | 6.33TCr | |
| -0.15% | +7.50% | +11.01% | +73.48% | 5.49TCr | |
| +0.57% | +4.60% | +10.07% | +92.86% | 5.33TCr | |
| -0.01% | +4.59% | +26.94% | +51.95% | 4.58TCr | |
| -1.12% | +2.30% | +21.78% | +123.77% | 4.35TCr | |
| +0.45% | +5.65% | +251.83% | +924.35% | 4.02TCr | |
| +0.05% | +6.75% | +14.48% | +56.75% | 3.35TCr | |
| +1.19% | -5.84% | +27.86% | -0.65% | 2.37TCr | |
| -0.38% | +5.68% | +36.43% | +27.54% | 2.38TCr | |
| Average | +0.18% | +0.22% | +51.90% | +157.90% | 3.84TCr | |
| Weighted average by Cap. | +0.42% | +0.55% | +47.82% | +159.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 2.46Cr 2.2Cr 2.03Cr 1.84Cr 3.44Cr 233.82Cr 3.5Cr 24Cr 9.68Cr 122.51Cr 9.24Cr 9.05Cr 386.22Cr |
| Net income | -9.45Cr -8.44Cr -7.8Cr -7.07Cr -13Cr -897.29Cr -13Cr -94Cr -37Cr -470.12Cr -35Cr -35Cr -1.48TCr | -14Cr -12Cr -11Cr -10Cr -19Cr -1.3TCr -19Cr -136.11Cr -54Cr -681.94Cr -51Cr -50Cr -2.15TCr |
| Net Debt | -19Cr -17Cr -16Cr -14Cr -27Cr -1.81TCr -27Cr -189.21Cr -75Cr -947.98Cr -72Cr -70Cr -2.99TCr | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $124.88 | -1.19% | 91,037 |
| 22/26/22 | $126.39 | -0.15% | 1,04,718 |
| 21/26/21 | $126.58 | +2.15% | 2,55,792 |
| 20/26/20 | $123.92 | +0.78% | 2,67,710 |
| 19/26/19 | $122.96 | +2.21% | 2,71,677 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PVLA Stock
Select your edition
All financial news and data tailored to specific country editions
